Stripping away the clues, suggestions, rumors etc. main point is Leronlimab could represent a strategic asset to the DOD. Then again, stripping away FDA slowdown, short interests etc, we might now be in a very different situation. I am not a trader, strictly playing the long game; when the grime is stripped away from the crystal ball we’ll all finally have clarity.